BACKGROUND: Many laboratories now report estimated glomerular filtration rate (eGFR) when a serum creatinine measurement is ordered. A summary of the impact of eGFR reporting in health care systems around the world for which it has been adopted is lacking. STUDY DESIGN: Systematic review of MEDLINE, EMBASE, other major databases, and conference proceedings of major nephrology meetings. SETTING & POPULATION: Any health care system in which eGFR reporting was introduced. SELECTION CRITERIA FOR STUDIES: Published studies or abstracts reporting patient, clinician, or health system outcomes of eGFR reporting. INTERVENTION: eGFR reporting. OUTCOMES: Volume of referrals or consults seen by nephrologists, changes in characteristics of patients who were seen, and prescription rates of kidney-related medications. RESULTS: 22 studies (10 full text and 12 conference abstracts) were identified in 2004-2010 from 5 countries. Nephrologist referrals and consultations increased after eGFR reporting, ranging from 13%-270%. The greatest increases in referrals were seen for the elderly, females, and those with stage 3 or higher chronic kidney disease (eGFR <60 mL/min/1.73 m(2)). Change in renin-angiotensin-aldosterone system-blocking drug use ranged from increases of 0%-6%. LIMITATIONS: Studies were highly variable in definition of outcomes. Reports were not available for many health care systems in which eGFR reporting was implemented. CONCLUSIONS: eGFR reporting has been associated with greater identification of patients with decreased kidney function in most health care systems that have reported its impact.
BACKGROUND: Many laboratories now report estimated glomerular filtration rate (eGFR) when a serum creatinine measurement is ordered. A summary of the impact of eGFR reporting in health care systems around the world for which it has been adopted is lacking. STUDY DESIGN: Systematic review of MEDLINE, EMBASE, other major databases, and conference proceedings of major nephrology meetings. SETTING & POPULATION: Any health care system in which eGFR reporting was introduced. SELECTION CRITERIA FOR STUDIES: Published studies or abstracts reporting patient, clinician, or health system outcomes of eGFR reporting. INTERVENTION: eGFR reporting. OUTCOMES: Volume of referrals or consults seen by nephrologists, changes in characteristics of patients who were seen, and prescription rates of kidney-related medications. RESULTS: 22 studies (10 full text and 12 conference abstracts) were identified in 2004-2010 from 5 countries. Nephrologist referrals and consultations increased after eGFR reporting, ranging from 13%-270%. The greatest increases in referrals were seen for the elderly, females, and those with stage 3 or higher chronic kidney disease (eGFR <60 mL/min/1.73 m(2)). Change in renin-angiotensin-aldosterone system-blocking drug use ranged from increases of 0%-6%. LIMITATIONS: Studies were highly variable in definition of outcomes. Reports were not available for many health care systems in which eGFR reporting was implemented. CONCLUSIONS: eGFR reporting has been associated with greater identification of patients with decreased kidney function in most health care systems that have reported its impact.
Authors: K Scott Brimble; Rajnish Mehrotra; Marcello Tonelli; Carmel M Hawley; Clare Castledine; Stephen P McDonald; Vicki Levidiotis; Azim S Gangji; Darin J Treleaven; Peter J Margetts; Michael Walsh Journal: J Am Soc Nephrol Date: 2013-08-29 Impact factor: 10.121
Authors: Virginia Wang; Matthew L Maciejewski; Bradley G Hammill; Rasheeda K Hall; Lynn Van Scoyoc; Amit X Garg; Arsh K Jain; Uptal D Patel Journal: Clin J Am Soc Nephrol Date: 2013-10-31 Impact factor: 8.237
Authors: Andrew K Roy; Catherine Mc Gorrian; Cecelia Treacy; Edel Kavanaugh; Alice Brennan; Niall G Mahon; Patrick T Murray Journal: Cardiorenal Med Date: 2013-02-26 Impact factor: 2.041
Authors: Khaled Abdel-Kader; Gary S Fischer; Jie Li; Charity G Moore; Rachel Hess; Mark L Unruh Journal: Am J Kidney Dis Date: 2011-10-07 Impact factor: 8.860
Authors: Braden Manns; Marcello Tonelli; Bruce Culleton; Peter Faris; Kevin McLaughlin; Rick Chin; Katherine Gooch; Finlay A McAlister; Ken Taub; Laurel Thorlacius; Richard Krause; Monica Kearns; Brenda Hemmelgarn Journal: Clin J Am Soc Nephrol Date: 2012-02-16 Impact factor: 8.237
Authors: Maya K Rao; Cynthia D Morris; Jean P O'Malley; Melinda M Davis; Motomi Mori; Sharon Anderson Journal: Clin J Am Soc Nephrol Date: 2013-01-31 Impact factor: 8.237